Skip to content

Time-Restricted Eating and Exercise for Bone Health

Time-Restricted Eating and Exercise Training to Enhance Bone Health in Adults With Osteopenia

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07824375
Acronym
OSTEO-FIT
Enrollment
24
Registered
2026-09-17
Start date
2026-11-01
Completion date
2028-04-30
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteopenia

Brief summary

The purpose of this study is to learn whether combining time-restricted eating with supervised resistance exercise can improve bone health in adults with osteopenia.

Interventions

BEHAVIORALTime-restricted eating combined with resistance exercise (TRE+Ex)

Participants in the TRE+Ex group will be asked to fast for a target of 16 hours per day, consuming food ad libitum within an 8-hour eating window beginning between 6:30 and 9:30 AM, 6 days per week for 12 weeks. They will also complete supervised progressive resistance exercise training 3 days per week.

BEHAVIORALHabitual eating pattern combined with resistance exercise (HE+Ex)

Participants in the HE+Ex group will be instructed to maintain their habitual eating patterns and complete supervised progressive resistance exercise training 3 days per week.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER
UAB Center for Exercise Medicine
CollaboratorUNKNOWN
UAB Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Men and women aged 50-75 years with body mass index (BMI) \>25kg/m2 * Osteopenia, defined as a T score between -1.0 and -2.5 at the lumbar spine, femoral neck, or total hip * Elevated adiposity, defined by waist circumference \>102 cm in men or \>88 cm in women * Stable health history over the past 2 months * Stable medication history over the past 2 months, as recommended by the primary provider * Willing and able to provide informed consent

Exclusion criteria

* Participation in a formal weight loss program, intentional caloric restriction, fasting \>10 hours/day, or ≥10 pounds weight loss within the past 3 months * Current participation in structured exercise training, supervised rehabilitation, or \>150 minutes/week of moderate intensity physical activity * Medical conditions or use of medications affecting bone metabolism * Diagnosed diabetes or use of insulin or glucose lowering medications * Resting heart rate \>120 beats/minute or daytime blood pressure ≥180/100 mmHg * Unstable angina, myocardial infarction, or stroke within the past 3 months * Continuous supplemental oxygen use for chronic pulmonary disease or heart failure * Rheumatoid arthritis, Parkinson's disease, dialysis, active cancer treatment within the past year, or diagnosed cognitive impairment * Absolute contraindications to exercise training according to American College of Sports Medicine guidelines * Unable to fast for 16 hours * Any condition that in the opinion of the investigator would impair ability to participate in the trial

Design outcomes

Primary

MeasureTime frameDescription
Bone mineral densityBaseline and 12 weeksmeasured by dual-energy X-ray absorptiometry
Bone mineral contentBaseline and 12 weeksmeasured by dual-energy X-ray absorptiometry

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026